Bypassing multidrug resistance in cancer cells with biodegradable polymer capsules

Adv Mater. 2010 Dec 14;22(47):5398-403. doi: 10.1002/adma.201003162.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibiotics, Antineoplastic / therapeutic use
  • Biocompatible Materials / chemistry*
  • Capsules / chemistry*
  • Cell Line, Tumor
  • Doxorubicin / therapeutic use
  • Doxorubicin / toxicity
  • Drug Resistance, Neoplasm
  • Humans
  • Neoplasms / drug therapy
  • Paclitaxel / therapeutic use
  • Paclitaxel / toxicity
  • Polymers / chemistry*
  • Polymethacrylic Acids / chemistry
  • Polyvinyls / chemistry
  • Pyrrolidines / chemistry

Substances

  • Antibiotics, Antineoplastic
  • Biocompatible Materials
  • Capsules
  • Polymers
  • Polymethacrylic Acids
  • Polyvinyls
  • Pyrrolidines
  • poly(N-vinylpyrrolidine)
  • polymethacrylic acid
  • Doxorubicin
  • Paclitaxel